Rsm Us Wealth Management »

G1 Therapeutics shares owned by Rsm Us Wealth Management

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Rsm Us Wealth Management from 13F filings

Historical chart of Rsm Us Wealth Management investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Rsm Us Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Rsm Us Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $152k 35k 4.32
2023-12-31 $108k 35k 3.05

More positions owned by Rsm Us Wealth Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Apple (AAPL)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust Internatnal Val (DFIV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Core Msci Eafe (IEFA)
Dimensional Etf Trust Us Equity Etf (DFUS)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Rsm Us Wealth Management

Top funds holding G1 Therapeutics

Vanguard Group
Raymond James & Associates
D. E. Shaw & Co
Standard Life Aberdeen
Marshall Wace
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Bank of America Corporation
Jane Street
Connor, Clark & Lunn Investment Management
Level Four Advisory Services
Two Sigma Investments
Man Group
Citadel Advisors
Two Sigma Advisers

View all funds holding G1 Therapeutics